Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 575647, 5 pages
http://dx.doi.org/10.1155/2012/575647
Research Article

Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation

Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT 84602, USA

Received 31 January 2012; Revised 3 April 2012; Accepted 26 April 2012

Academic Editor: Peter E. Schwartz

Copyright © 2012 Melissa M. Alegre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Stuart-Harris, C. Caldas, S. E. Pinder, and P. Pharoah, “Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients,” Breast, vol. 17, no. 4, pp. 323–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Mukhtar, A. P. Moore, O. Nseyo et al., “Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity,” Breast Cancer Research and Treatment, vol. 130, no. 2, pp. 635–644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Nikolényi, G. Uhercsák, M. Csenki et al., “Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy,” Pathology and Oncology Research, vol. 18, no. 1, pp. 61–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Mao, J. Wu, N. Wang et al., “A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer,” Cancer Investigation, vol. 20, no. 7-8, pp. 922–931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Gasparri, N. Wang, S. Skog, A. Galvani, and S. Eriksson, “Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays,” European Journal of Cell Biology, vol. 88, no. 12, pp. 779–785, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Hengstschläger, M. Pfeilstöcker, and E. Wawra, “Thymidine kinase expression—a marker for malignant cells,” Advances in Experimental Medicine and Biology, vol. 431, pp. 455–460, 1998. View at Google Scholar
  7. W. Mikulits, M. Hengstschläger, T. Sauer, E. Wintersberger, and E. W. Müllner, “Overexpression of thymidine kinase mRNA eliminates cell cycle regulation of thymidine kinase enzyme activity,” Journal of Biological Chemistry, vol. 271, no. 2, pp. 853–860, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Nisman, V. Yutkin, H. Nechushtan et al., “Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy,” Urology, vol. 76, no. 2, pp. 513.e1–513.e6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Nisman, T. Allweis, L. Kaduri et al., “Serum thymidine kinase 1 activity in breast cancer,” Cancer Biomarkers, vol. 7, no. 2, pp. 65–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Li, Y. Wang, J. He et al., “Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas,” European Journal of Cancer Prevention, vol. 19, no. 4, pp. 313–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Svobodova, O. Topolcan, L. Holubec et al., “Prognostic importance of thymidine kinase in colorectal and breast cancer,” Anticancer Research, vol. 27, no. 4 A, pp. 1907–1909, 2007. View at Google Scholar · View at Scopus
  12. Q. He, T. Fornander, H. Johansson et al., “Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer,” Anticancer Research, vol. 26, no. 6, pp. 4753–4759, 2006. View at Google Scholar · View at Scopus
  13. K. L. O'Neill, M. Hoper, and G. W. Odling-Smee, “Can thymidine kinase levels in breast tumors predict disease recurrence?” Journal of the National Cancer Institute, vol. 84, no. 23, pp. 1825–1828, 1992. View at Google Scholar · View at Scopus
  14. J. A. Foekens, S. Romain, M. P. Look, P. M. Martin, and J. G. M. Klijn, “Thymidine kinase and thymidylate synthase in advanced breast cancer: Response to tamoxifen and chemotherapy,” Cancer Research, vol. 61, no. 4, pp. 1421–1425, 2001. View at Google Scholar · View at Scopus
  15. E. He, X. H. Xu, H. Guan et al., “Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma,” Nucleosides, Nucleotides and Nucleic Acids, vol. 29, no. 4–6, pp. 352–358, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Q. He, Y. Mao, J. Wu et al., “Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas,” International journal of oncology, vol. 25, no. 4, pp. 945–953, 2004. View at Google Scholar · View at Scopus
  17. H. Guan, Y. Sun, Q. Zan et al., “Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: a useful tool in tumor therapy management,” Molecular Medicine Reports, vol. 2, no. 6, pp. 923–929, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Huang, J. Lin, N. Guo et al., “Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 2, pp. 497–505, 2011. View at Google Scholar · View at Scopus
  19. T. Votava, O. Topolcan, L. Holubec et al., “Changes of serum thymidine kinase in children with acute leukemia,” Anticancer Research, vol. 27, no. 4, pp. 1925–1928, 2007. View at Google Scholar · View at Scopus
  20. K. L. O'Neill, M. R. Buckwalter, and B. K. Murray, “Thymidine kinase: diagnostic and prognostic potential,” Expert Review of Molecular Diagnostics, vol. 1, no. 4, pp. 428–433, 2001. View at Google Scholar · View at Scopus